Carlos Fernandez-Hernando

Associate Professor of Comparative Medicine and of Pathology

Departments & Organizations

Yale Combined Program in the Biological and Biomedical Sciences (BBS): Molecular Medicine, Pharmacology, and Physiology

Center for RNA Science and Medicine, Yale

Comparative Medicine: Integrative Cell Signaling & Neurobiology of Metabolism (ICSNM)

Pathology: ExPath

Research Interests

Cholesterol homeostasis; Lipoprotein metabolism; Post-transcriptional regulation; microRNAs; Atherosclerosis; RNAi screening


  • Ph.D., Universidad Autonoma, Madrid, Spain, 2003

Selected Publications

  • miR-33 regulates glucose production. Ramírez CM, Goedeke L, Rotllan N, Yoon JH, Mattison JA, Suarez Y, de Cabo R, Gorospe M, and Fernández-Hernando C. Mol Cell Biol. 2013. Aug;33(15):28911-202.
  • miR-30c lowers lipid synthesis and lipoprotein secretion to reduce hyperlipidemia and atherosclerosis. Soh J, Iqpal J, Queiroz J, Fernández-Hernando C and Hussain MM. Nat Med. 2013. Jul;19(7):892-900.
  • Control of cholesterol metabolism and plasma HDL levels by miR-144. Ramírez CM, Rotllan N, Vlassov AV, Dávalos A, Li M, Goedeke L, Cirera-Salinas D, Kim J, Araldi E, Yoon H, Salerno A, Wanschel A, Nelson PT, Castrillo A, Kim J, Suárez Y and Fernández-Hernando C. Circ Res. 2013. Jun 7;112(12):1592-601.


Latest News


Edit Profile